Topic

Vaccine Sales

A collection of 1 issue

Merck & Co.'s Stock Falls 8.75% Amid Weak Gardasil Sales in China

Merck & Co.'s stock faced an 8.75% drop in 2024, linked to reduced Gardasil vaccine sales in China. Explore the impact on Merck's market performance.